Monodisperse oligoethylene glycols modified Camptothecin, 10-Hydroxycamptothecin (cas 19685-09-7) and SN38 prodrugs

Add time:09/03/2019    Source:sciencedirect.com

Camptothecin, which represents a class of natural products with high anticancer activity, suffers low water solubility which hampers its clinic application. To address this issue, monodisperse polyethylene glycols were employed to modify this class of natural products, including Camptothecin, 10-Hydroxycamptothecin (cas 19685-09-7), and SN38. Through selective modification with a series of monodisperse polyethylene glycols, 31 Camptothecin derivatives, including 9 ethers and 22 carbonates, were prepared using a macrocyclic sulfate-based strategy with high efficacy. Monodisperse polyethylene glycols modification provided the Camptothecin derivatives with high purity and fine-tunable water solubility. Through the physicochemical and biological assays, a few novel prodrugs with good solubility, cytotoxicity, and valuable drug release profile were identified as promising anticancer drug candidates.

We also recommend Trading Suppliers and Manufacturers of 10-Hydroxycamptothecin (cas 19685-09-7). Pls Click Website Link as below: cas 19685-09-7 suppliers

Prev:ORIGINAL ARTICLEMenthol-modified casein nanoparticles loading 10-Hydroxycamptothecin (cas 19685-09-7) for glioma targeting therapy
Next:Incorporation of 10-Hydroxycamptothecin (cas 19685-09-7) nanocrystals into zein microspheres)